• Feb 12, 2025

Biogen’s (NASDAQ:BIIB) Q4 Sales Top Estimates

Biotech company Biogen (NASDAQ:BIIB) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 2.9% year on year to $2.45 billion. Its non-GAAP profit of $3.44 per share was 2.3% above analysts’ consensus estimates.

  • Feb 12, 2025

Lithia (NYSE:LAD) Surprises With Q4 Sales, Stock Soars

Automotive retailer Lithia Motors (NYSE:LAD) announced better-than-expected revenue in Q4 CY2024, with sales up 20.2% year on year to $9.22 billion. Its non-GAAP profit of $7.79 per share was 8.2% above analysts’ consensus estimates.

  • Feb 12, 2025

Denny's (NASDAQ:DENN) Misses Q4 Sales Targets

Diner restaurant chain Denny’s (NASDAQ:DENN) fell short of the market’s revenue expectations in Q4 CY2024, with sales flat year on year at $114.7 million. Its non-GAAP profit of $0.14 per share was 8.6% below analysts’ consensus estimates.

  • Feb 12, 2025

Traders’ Bets on Higher US Rates Face Crucial Inflation Data

(Bloomberg) -- Traders who have been piling into wagers for higher US yields ever since last week’s jobs report will see their convictions tested with the latest inflation readings. Most Read from BloombergSaudi Arabia’s Neom Signs $5 Billion Deal for AI Data CenterWhy American Mobility Ground to a HaltThe Forgotten French Architect Who Rebuilt MarseilleIn New Orleans, an Aging Dome Tries to Stay SuperTreasury yields remained higher on Wednesday after steadily climbing in the wake of data Friday